Arenaviruses other than Lassa virus

Antiviral Research

Volumn 57, Issue 1-2, 2003, Pages 89-100

  Charrel, Rémi N ^a   De Lamballerie, Xavier ^a  

^a Aix Marseille University IRD 190 Inserm 1207   (France)

Author keywords

Arenavirus; Bioterrorism; Guanarito virus; Junin virus; Lassa virus; Machupo virus; Ribavirin; Sabia virus; Viral hemorrhagic fever

Indexed keywords

5 ETHYNYL 4 IMIDAZOLECARBOXAMIDE 1 RIBOSIDE; 5 FLUORO 1 BETA DEXTRO RIBOFURANOSYLIMIDAZOLE 4 CARBOXAMIDE; ANTIBODY; ANTIVIRUS AGENT; BLOOD CLOTTING FACTOR; CARRAGEENAN; CHLORPROMAZINE; DEXTRAN SULFATE; FUCOIDIN; HEPARIN; INOSINATE DEHYDROGENASE INHIBITOR; LIVE VACCINE; MYRISTIC ACID DERIVATIVE; NUCLEOSIDE ANALOG; PENTOSAN POLYSULFATE; PHENOTHIAZINE; PIRAZOFURIN; RIBAMIDINE; RIBAVIRIN; SELENAZOFURIN; TIAZOFURIN; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANEMIA; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARENAVIRUS; BIOSAFETY; CENTRAL NERVOUS SYSTEM MALFORMATION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; FATALITY; FLUID THERAPY; GUANARITO VIRUS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOTHERAPY; INFECTION CONTROL; INFECTION PREVENTION; INHALATION; JUNIN VIRUS; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACHUPO ARENAVIRUS; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; RODENT CONTROL; SABIA VIRUS; THROMBOCYTOSIS; VACCINATION; VIRUS DIAGNOSIS; VIRUS HEMORRHAGIC FEVER; VIRUS ISOLATION; VIRUS TRANSMISSION;

ARENAVIRIDAE; ARENAVIRUS; GUANARITO VIRUS; JUNIN VIRUS; LASSA VIRUS; MACHUPO VIRUS; SABIA VIRUS;

EID: 0037288074     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00202-4     Document Type: Article

References (96)

1. Adair C.V., Gauld R.L., Smadel J.E. Aseptic meningitis, a disease of diverse etiology: clinical and etiologic studies on 854 cases. Ann. Intern. Med. 39:1953;675-704.
2. Andrei G., De Clercq E. Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res. 14:1990;287-299.
3. Armstrong C., Sweet L.K. Lymphocytic choriomeningitis. Public Health Rep. 54:1939;673.
4. Barrera Oro J.G., McKee K.T. Jr. Toward a vaccine against Argentine hemorrhagic fever. Bull. Pan. Am. Health Organ. 25:1991;118-126.
5. Barton L.L., Hyndman N.J. Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. Pediatrics. 105:2000;E35.
6. Barton L.L., Budd S.C., Morfitt W.S., Peters C.J., Ksiazek T.G., Schindler R.F., Yoshino M.T. Congenital lymphocytic choriomeningitis virus infection in twins. Pediatr. Infect. Dis. J. 12:1993;942-946.
7. Barry M., Russi M., Armstrong L., Geller D., Tesh R., Dembry L., Gonzalez J.P., Khan A.S., Peters C.J. Brief report: treatment of a laboratory-acquired Sabia virus infection. N. Engl. J. Med. 333:1995;294-296.
8. Bennett S.G., Milazzo M.L., Webb J.P. Jr., Fulhorst C.F. Arenavirus antibody in rodents indigenous to coastal southern California. Am. J. Trop. Med. Hyg. 62:2000;626-630.
9. Biggar R.J., Douglas R.G., Hotchin J. Letter: lymphocytic choriomeningitis associated with hamsters. Lancet. i:1975;856-857.
10. Blumenthal W., Ackermann R., Scheid W. Distribution of the lymphocytic choriomeningitis virus in an endemic area. Dtsch. Med. Wochenschr. 93:1968;944-948.
11. Bockstahler L.E., Carney P.G., Bushar G., Sagripanti J.L. Detection of Junin virus by the polymerase chain reaction. J. Virol. Methods. 39:1992;231-235.
12. Bowen M.D., Peters C.J., Nichol S.T. The phylogeny of New World (Tacaribe complex) arenaviruses. Virology. 219:1996;285-290.
13. Bowen M.D., Peters C.J., Nichol S.T. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol. Phylogenet. E. 8:1997;301-316.
14. Bowen, M.D., Trappier, S.G., Sanchez, A.J., Meyer, R.F., Goldsmith, C.S., Zaki, S.R., Dunster, L.M., Peters, C.J., Ksiazek, T.G., Nichol, S.T., the RVF Task Force, 2001. A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology 291, 185-190.
15. Buchmeier M., Adam E., Rawls W.E. Serological evidence of infection by Pichinde virus among laboratory workers. Infect. Immun. 9:1974;821-823.
16. Candurra N.A., Maskin L., Damonte E.B. Inhibition of arenavirus multiplication in vitro by phenotiazines. Antiviral Res. 31:1996;149-158.
17. Canonico P.G., Jahrling P.B., Pannier W.L. Antiviral efficacy of pyrazofurin against selected RNA viruses. Antiviral Res. 2:1982;331-337.
18. Carballal G., Calello M.A., Laguens R.P., Weissenbacher M.C. Tacaribe virus: a new alternative for Argentine hemorrhagic fever vaccine. J. Med. Virol. 23:1987a;257-263.
19. Carballal G., Oubina J.R., Molinas F.C., Nagle C., de la Vega M.T., Videla C., Elsner B. Intracerebral infection of Cebus apella with the XJ-Clone 3 strain of Junin virus. J. Med. Virol. 21:1987b;257-268.
20. Carey D.E., Kemp G.E., White H.A., Pinneo L., Addy R.F., Fom A.L., Stroh G., Casals J., Henderson B.E. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans. R. Soc. Trop. Med. Hyg. 66:1972;402-408.
21. CDC. Center for Disease Control and Prevention, 1988. Management of patients with suspected viral hemorrhagic fever. MMWR Morb. Mortal. Wkly. Rep. 37 (Suppl S3) 1-16.
22. CDC. Center for Disease Control and Prevention, 1994. Bolivian hemorrhagic fever-El Beni Department, Bolivia, 1994. MMWR Morb. Mortal. Wkly. Rep. 43, 943-946.
23. CDC. Center for Disease Control and Prevention, 2000a. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Morb. Mortal. Wkly. Rep. 49 (RR-4), 1-14.
24. CDC. Center for Disease and Control and Prevention, 2000b. Fatal illnesses associated with a new world arenavirus - California, 1999-2000. MMWR Morb. Mortal. Wkly. Rep. 49, 709-711.
25. Charrel R.N., de Lamballerie X., Fulhorst C.F. The Whitewater Arroyo virus: natural evidence for genetic recombination among Tacaribe serocomplex viruses (family Arenaviridae). Virology. 283:2001a;161-166.
26. Charrel R.N., de Lamballerie X., De Micco P., Fulhorst C.F. Nucleotide sequence of the pirital virus (family Arenaviridae) small genomic segment. Biochem. Biophys. Res. Commun. 280:2001b;1402-1407.
27. Charrel R.N., Feldmann H., Fulhorst C.F., Khelifa R., de Chesse R., de Lamballerie X. Phylogeny of New World arenaviruses based on the complete coding sequences of the small genomic segment identified an evolutionary lineage produced by intra-segmental recombination. Biochem. Biophys. Res. Commun. 296:2002;1118-1124.
28. Childs, J.E., Peters, C.J., 1993. Ecology and epidemiology of arenaviruses and their hosts. In: Salvato, M.S. (Ed.), The Arenaviridae. Plenum, New York, pp. 331-373.
29. Childs J.E., Glass G.E., Ksiazek T.G., Rossi C.A., Oro J.G., Leduc J.W. Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population. Am. J. Trop. Med. Hyg. 44:1991;117-121.
30. Clegg, J.C.S., Bowen, M.D., Buchmeier, M.J., Gonzalez, J.P., Lukashevich, I.S., Peters, C.J., Rico-Hesse, R., Romanowski, V., 2000. Arenaviridae. In: Van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L., Carsten, E.B., Estes, M.K., Lemon, S.M., Maniloff, J., Mayo, M.A., McGeoch, D.J., Pringle, C.R., Wickner, R.B. (Eds.), Virus Taxonomy. Seventh Report of the International Committee for the Taxonomy of Viruses. Academic Press, New York, pp. 633-640.
31. Cordo S.M., Candurra N.A., Damonte E.B. Myristic acid analogs are inhibitors of Junin virus replication. Microb. Infect. 1:1999;609-614.
32. Danes L., Benda R., Fuchsova M. Experimental inhalation infection with the mymphocytic choriomeningitis virus (WE strain) of the monkeys of the Macacus cynomolgus and Macacus rhesus species. Bratisl. Lek. Listy. 43:1963;21-34.
33. De Clercq E., Cools M., Balzarini J., Snoeck R., Andrei G., Hosoya M., Shigeta S., Ueda T., Minakawa N., Matsuda A. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide and related compounds. Antimicrob. Agents Chemother. 35:1991;679-684.
34. Deibel R., Woodall J.P., Decher W.J., Schryver G.D. Lymphocytic choriomeningitis virus in man. Serologic evidence of association with pet hamsters. JAMA. 232:1975;501-504.
35. Enria, D.A., Feuillade, M.R., 1998. Argentine haemorrhagic fever (Junin virus, Arenaviridae): a review on clinical, epidemiological, ecological, treatment and preventive aspects of the disease. In: Travassos da Rosa, A.P.A., Vasconcelos, P.F.C., Travassos da Rosa, J.F.S. (Eds.), An overview of arbovirology in Brazil and neighboring countries, Instituto Evandro Chaggas, Belem, Brazil, pp. 219-232.
36. Enria D.A., Briggiler A.M., Levis S., Vallejos D., Maiztegui J.I., Canonico P.G. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res. 7:1987;353-359.
37. Enria D.A., Briggiler A.M., Fernandez N.J., Levis S.C., Maiztegui J.I. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet. ii:1984;255-256.
38. Eriksson B., Helgstrand E., Johansson N.G., Larsson A., Misiorny A., Noren J.O., Philipson L., Stenberg K., Stening G., Stridh S., Oberg B. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob. Agents Chemother. 11:1977;946-951.
39. Harrison L.H., Halsey N.A., McKee K.T. Jr., Peters C.J., Barrera Oro J.G., Briggiler A.M., Feuillade M.R., Maiztegui J.I. Clinical case definitions for Argentine hemorrhagic fever. Clin. Infect. Dis. 28:1999;1091-1094.
40. Hinman A.R., Fraser D.W., Douglas R.G., Bowen G.S., Kraus A.L., Winkler W.G., Rhodes W.W. Outbreak of lymphocytic choriomeningitis virus infections in medical center personnel. Am. J. Epidemiol. 101:1975;103-110.
41. Huggins J.W. Prospects for treatment of viral hemorrhagic fevers with ribavirin a broad-spectrum antiviral drug. Rev. Infect. Dis. 11(Suppl. 4):1989;S750-S761.
42. Huggins J.W., Robins R.K., Canonico P.G. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob. Agents Chemother. 26:1984;476-480.
43. Jahrling P.B., Hesse R.A., Eddy G.A., Johnson K.M., Callis R.T., Stephen E.L. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 141:1980;580-589.
44. Johnson K.M., Halstead S.B., Cohen S.N. Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog. Med. Virol. 9:1967;105-158.
45. Kenyon R.H., Canonico P.G., Green D.E., Peters C.J. Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob. Agents Chemother. 29:1986;521-523.
46. Kilgore P.E., Ksiazek T.G., Rollin P.E., Mills J.N., Villagra M.R., Montenegro M.J., Costales M.A., Paredes L.C., Peters C.J. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24:1997;718-722.
47. Kirsi J.J., North J.A., McKernan P.A., Murray B.K., Canonico P.G., Huggins J.W., Srivastava P.C., Robins R.K. Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob. Agents Chemother. 24:1983;353-361.
48. Kosoy M.Y., Elliott L.H., Ksiazek T.G., Fulhorst C.F., Rollin P.E., Childs J.E., Mills J.N., Maupin G.O., Peters C.J. Prevalence of antibodies to arenaviruses in rodents from the southern and western United States: evidence for an arenavirus associated with the genus Neotoma. Am. J. Trop. Med. Hyg. 54:1996;570-576.
49. Kuns M.L. Epidemiology of Machupo virus infection. Part II. Ecological and control studies of hemorrhagic fever. Am. J. Trop. Med. Hyg. 14:1965;813-816.
50. Lehmann-Grube F. Portraits of viruses: arenaviruses. Intervirology. 22:1984;121-145.
51. Lozano M.E., Enri D., Maiztegui J.I., Grau O., Romanowski V. Rapid diagnosis of Argentine hemorrhagic fever by reverse transcriptase PCR-based assay. J. Clin. Microbiol. 33:1995;1327-1332.
52. Lozano M.E., Ghiringhelli P.D., Romanowski V., Grau O. A simple nucleic acid amplification assay for the rapid detection of Junin virus in whole blood samples. Virus Res. 27:1993;37-53.
53. Lozano M.E., Posik D.M., Albarino C.G., Schujman G., Ghiringhelli P.D., Calderon G., Sabattini M., Romanowski V. Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterized arenaviruses. Virus Res. 49:1997;79-89.
54. Lucia H.L., Coppenhaver D.H., Baron S. Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin. Antiviral Res. 12:1989;279-292.
55. Lukashevich I.S. Generation of reassortants between African arenaviruses. Virology. 188:1992;600-605.
56. Lunkenheimer K., Hufert F.T., Schmitz H. Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J. Clin. Microbiol. 28:1990;2689-2692.
57. Maiztegui J.I. Clinical and epidemiological patterns of Argentine haemorrhagic fever. Bull. World Health Organ. 52:1975;567-575.
58. Maiztegui J.I., Fernandez N.J., de Damilano A.J., Maiztegui J.I. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet. ii:1979;1216-1217.
59. Maiztegui J.I., Feuillade M., Briggiler A. Progressive extension of the endemic area and changing incidence of Argentine hemorrhagic fever. Med. Microbiol. Immunol. 175:1986;149-152.
60. Maiztegui J.I., McKee K.T. Jr., Barrera Oro J.G., Harrison L.H., Gibbs P.H., Feuillade M.R., Enria D.A., Briggiler A.M., Levis S.C., Ambrosio A.M., Halsey N.A., Peters C.J. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J. Infect. Dis. 177:1998;277-283.
61. de Manzione N., Salas R.A., Paredes H., Godoy O., Rojas L., Araoz F., Fulhorst C.F., Ksiazek T.G., Mills J.N., Ellis B.A., Peters C.J., Tesh R.B. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin. Infect. Dis. 26:1998;308-313.
62. Marr J.S., Kiracofe J.B. Was the huey cocoliztli a haemorrhagic fever? Med. Hist. 44:2000;341-362.
63. McKee K.T. Jr., Huggins J.W., Trahan C.J., Mahlandt B.G. Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob. Agents Chemother. 32:1988;1304-1309.
64. McKee K.T. Jr., Oro J.G., Kuehne A.I., Spisso J.A., Mahlandt B.G. Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in Rhesus macaques. Intervirology. 34:1992;154-163.
65. Mercado R. Rodent control programmes in areas affected by Bolivian haemorrhagic fever. Bull. World Health Organ. 52:1975;691-696.
66. Meyer H.M., Johnson R.T., Crawford E.P., Dascomb H.E., Rogers N.G. Central nervous system syndromes of "viral" etiology: a study of 713 cases. Am. J. Med. 29:1960;334-347.
67. Mills J.N., Ellis B.A., McKee K.T. Jr., Ksiazek T.G., Oro J.G., Maiztegui J.I., Calderon G.E., Peters C.J., Childs J.E. Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am. J. Trop. Med. Hyg. 44:1991;589-597.
68. Moncayo A.C., Hice C.L., Watt D.M., Travassos de Rosa A.P., Guzman H., Russell K.L., Calampa C., Gozalo A., Popov V.L., Weaver S.C., Tesh R.B. Allpahuayo virus: a newly recognized arenavirus (arenaviridae) from arboreal rice rats (Oecomys bicolor and Oecomys paricola) in northeastern Peru. Virology. 284:2001;277-286.
69. Park J.Y., Peters C.J., Rollin P.E., Ksiazek T.G., Katholi C.R., Waites K.B., Gray B., Maetz H.M., Stephensen C.B. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am. J. Trop. Med. Hyg. 57:1997;37-41.
70. Parodi A.S., Greenway D.J., Ruggiero H.R., Rivero E., Frigerio M.J., de la Barrera J.M., Mettler N.E., Garzon F., Boxaca M.C., Guerrero L.B., Nota N.R. Sobre la etiologia del brote epidemico de Junin (nota previa). Dia. Med. 30:1958;62.
71. Peters C.J., Webb P.A., Johnson K.M. Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc. Soc. Exp. Biol. Med. 142:1973;526-531.
72. Peters C.J., Kuehne R.W., Mercado R.R., Le Bow R.H., Spertzel R.O., Webb P.A. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am. J. Epidemiol. 99:1974;425-433.
73. Peters C.J., Jahrling P.B., Liu C.T., Kenyon R.H., McKee K.T. Jr., Barrera Oro J.G. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 134:1987;5-68.
74. Peters C.J., Buchmeier M., Rollin P.E., Ksiazek T.G. 1996a. Arenaviruses. In: Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, R., Straus, S.E. (Eds.), Fields Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA, pp. 1521-1551.
75. Peters C.J., Jahrling P.B., Khan A.S. Patients infected with high-hazard viruses: scientific basis for infection control. Arch. Virol. 11:1996b;141-168.
76. Promed, 2002. Venezuelan hemorrhagic fever-Venezuela, reference 20020203.3467.
77. Riviere Y., Oldstone M.B. Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis. J. Virol. 59:1986;363-368.
78. Riviere Y., Ahmed R., Oldstone M.B. The use of lymphocytic choriomeningitis virus reassortants to map viral genes causing virulence. Med. Microbiol. Immunol. 175:1986;191-192.
79. Rodriguez M., McCormick J.B., Weissenbacher M.C. Antiviral effect of ribavirin on Junin virus replication in vitro. Rev. Argent. Microbiol. 18:1986;69-74.
80. Rousseau M.C., Saron M.F., Brouqui P., Bourgeade A. Lymphocytic choriomeningitis virus in southern France: four case reports and a review of the literature. Eur. J. Epidemiol. 13:1997;817-823.
81. Sabattini M.S., Gonzalez de Rios L.E., Diaz G V.R. Enfeccion natural y experimental de roedores con virus Junin. Medicina (Buenos Aires). 37:1977;149-161.
82. Scholtissek C. Inhibition of influenza RNA synthesis by virazole (ribavirin). Arch. Virol. 50:1976;349-352.
83. Sidwell R.W., Huffman J.H., Call E.W., Alaghamandan H., Cook P.D., Robins R.K. Activity of selenazofurin against influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 28:1985;375-377.
84. Skinner H.H., Knight E.H., Buckley L.S. The hamster as a secondary reservoir host of lymphocytic choriomeningitis virus. J. Hyg. Lond. 76:1976;299-306.
85. Smee D.F., Gilbert J., Leonhardt J.A., Barnett B.B., Huggins J.H., Sidwell R.W. Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine selenazofurin and ampligen. Antiviral Res. 20:1993;57-70.
86. Smithard E.H.R., Macrae A.D. Lymphocytic choriomeningitis associated human and mouse infection. Br. Med. J. 51:1951;1299.
87. Smee D.F., Morris J.L., Barnard D.L., Van Aerschot A. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3′-fluoro-3′-deoxyadenosine. Antiviral Res. 18:1992;151-162.
88. Southern, P.J., 1996. Arenaviruses. In: Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, R., Straus, S.E. (Eds.), Fields Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA, pp. 1505-1519.
89. Stephensen C.B., Jahrling P.B. Experimental Lassa fever virus infection successfully treated with ribavirin. Lancet. i:1979;268-269.
90. Stephenson E.H., Larson E.W., Dominik J.W. Effect of environmental factors on aerosol-induced Lassa virus infection. J. Med. Virol. 14:1984;295-303.
91. Stephensen C.B., Blount S.R., Lanford R.E., Holmes K.V., Montali R.J., Fleenor M.E., Shaw J.F. Prevalence of serum antibodies against lymphocytic choriomeningitis virus in selected populations from two US cities. J. Med. Virol. 38:1992;27-31.
92. Streeter D.G., Witkowski J.T., Khare G.P., Sidwell R.W., Bauer R.J., Robins R.K., Simon L.N. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole) a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. U.S.A. 70:1973;1174-1178.
93. Vainrub B., Salas R. Latin American hemorrhagic fever. Infect. Dis. Clin. N. Am. 8:1994;47-59.
94. Vanzee B.E., Douglas R.G., Betts R.F., Bauman A.W., Fraser D.W., Hinman A.R. Lymphocytic choriomeningitis in university hospital personnel clinical features. Am. J. Med. 58:1975;803-809.
95. Weaver S.C., Salas R.A., de Manzione N., Fulhorst C.F., Duno G., Utrera A., Mills J.N., Ksiazek T.G., Tovar D., Tesh R.B. Guanarito virus (Arenaviridae) isolates from endemic and outlying localities in Venezuela: sequence comparisons among and within strains isolated from Venezuelan hemorrhagic fever patients and rodents. Virology. 266:2000;189-195.
96. Weissenbacher M.C., Calello M.A., Merani M.S., McCormick J.B., Rodriguez M. Therapeutic effect of the antiviral agent ribavirin in Junin virus infection of primates. J. Med. Virol. 20:1986;261-267.